Xylem Inc. (NYSE:XYL) had its price objective raised by equities researchers at Oppenheimer Holdings, Inc. from $60.00 to $66.00 in a research report issued on Wednesday, August 2nd. The firm currently has an “outperform” rating on the industrial products company’s stock. Oppenheimer Holdings, Inc.’s price target would suggest a potential upside of 11.64% from the company’s current price. Oppenheimer Holdings also issued estimates for Xylem’s Q4 2017 earnings at $0.77 EPS, FY2017 earnings at $2.37 EPS, FY2018 earnings at $2.75 EPS and FY2019 earnings at $3.10 EPS.
Several other analysts have also commented on the stock. Barclays PLC raised shares of Xylem from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $51.00 to $59.00 in a research report on Monday, May 15th. BidaskClub raised shares of Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. CIBC reaffirmed a “buy” rating and issued a $58.00 price objective on shares of Xylem in a research report on Thursday, April 6th. BMO Capital Markets initiated coverage on shares of Xylem in a research report on Wednesday, June 21st. They issued an “outperform” rating and a $60.00 price objective on the stock. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $52.00 price objective on shares of Xylem in a research report on Thursday, July 6th. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $59.00.
Shares of Xylem (XYL) opened at 59.12 on Wednesday. The stock has a 50 day moving average price of $56.81 and a 200-day moving average price of $51.96. Xylem has a 12-month low of $45.60 and a 12-month high of $60.71. The stock has a market cap of $10.62 billion, a price-to-earnings ratio of 38.17 and a beta of 1.18.
Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. Xylem had a net margin of 7.08% and a return on equity of 16.02%. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the firm earned $0.48 earnings per share. The firm’s revenue was up 24.9% on a year-over-year basis. Equities analysts anticipate that Xylem will post $2.37 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2017/08/12/xylem-inc-xyl-price-target-increased-to-66-00-by-analysts-at-oppenheimer-holdings-inc-updated.html.
In other Xylem news, insider Kenneth Napolitano sold 9,052 shares of the business’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $60.16, for a total value of $544,568.32. Following the completion of the transaction, the insider now owns 35,303 shares of the company’s stock, valued at approximately $2,123,828.48. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Steven R. Loranger sold 66,132 shares of the business’s stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $55.01, for a total transaction of $3,637,921.32. Following the completion of the transaction, the director now directly owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The disclosure for this sale can be found here. 0.75% of the stock is owned by insiders.
Large investors have recently made changes to their positions in the stock. Virtu KCG Holdings LLC acquired a new stake in shares of Xylem during the second quarter worth about $621,000. Baker Avenue Asset Management LP boosted its stake in shares of Xylem by 8.4% in the second quarter. Baker Avenue Asset Management LP now owns 16,336 shares of the industrial products company’s stock worth $906,000 after buying an additional 1,262 shares during the period. Parametric Portfolio Associates LLC boosted its stake in shares of Xylem by 42.0% in the second quarter. Parametric Portfolio Associates LLC now owns 361,578 shares of the industrial products company’s stock worth $20,042,000 after buying an additional 106,976 shares during the period. WealthPLAN Partners LLC acquired a new stake in shares of Xylem during the second quarter worth about $267,000. Finally, Advisor Group Inc. boosted its stake in shares of Xylem by 18.3% in the second quarter. Advisor Group Inc. now owns 3,592 shares of the industrial products company’s stock worth $198,000 after buying an additional 555 shares during the period. 86.41% of the stock is owned by institutional investors.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
What are top analysts saying about Xylem Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Xylem Inc. and related companies.